Balance Sheet
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2019 - 2025)

Cellebrite DI (CLBT) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $241.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 15.35% year-over-year to $241.6 million; the TTM value through Dec 2025 reached $241.6 million, up 15.35%, while the annual FY2025 figure was $241.6 million, 15.35% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $241.6 million in Q4 2025 per CLBT's latest filing, up from $209.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $241.6 million in Q4 2025 and bottomed at $144.0 million in Q4 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $193.6 million, with a median of $190.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 26.87% in 2022, then increased 4.08% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $144.0 million in 2021, then rose by 26.87% to $182.7 million in 2022, then increased by 4.08% to $190.2 million in 2023, then rose by 10.16% to $209.5 million in 2024, then rose by 15.35% to $241.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $241.6 million in Q4 2025, $209.5 million in Q4 2024, and $190.2 million in Q4 2023.